Sheila Gujrathi is Director at Ventyx Biosciences, Inc. (VTYX). They have made 3 open-market trades across 2 companies since 2014, most recently 2026-03-04.
CIK 0001575202
2 open-market purchases totalling $468K since 2019, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VTYX | BUY | 2024-12-23 | 2024-12-26 | $2.31 | $300K | -9.3% | -17.3% | -50.8% |
| VTYX | SELL | 2023-03-30 | 2023-03-31 | $33.73 | $6.7M | -8.0% | +17.6% | -4.4% |
| GOSS | BUY | 2019-09-27 | 2019-09-27 | $16.80 | $168K | -9.1% | +12.8% | -5.4% |
| RCPT | SELL · 10b5-1 | 2014-11-11 | 2014-11-12 | $108.99 | $3.3M | N/A | N/A | N/A |
| RCPT | SELL · 10b5-1 | 2014-09-22 | 2014-09-24 | $61.45 | $1.8M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.